Richard Zink
Richard Zink RSS
Research Statistician Developer

Richard C. Zink, PhD, is a research statistician developer for JMP. He joined SAS in 2011 after eight years in the pharmaceutical industry, where he designed and analyzed clinical trials in multiple therapeutic areas and participated in US and European drug submissions and FDA advisory committee hearings. He holds a PhD in biostatistics from the University of North Carolina at Chapel Hill.

Recent Posts

JMP Clinical at CDISC European Interchange

Richard Zink|April 26, 20127240
Every year, the Clinical Data Interchange Standards Consortium (CDISC) holds several Interchange events that take place in the US, Europe and Asia. These meetings have several ... Read More

Accounting for the time at which an adverse event occurs

Richard Zink|December 6, 201112910
In a previous post, I described how JMP Clinical allows you to specify time windows within an incidence analysis. Specifying time windows can provide a ... Read More

Discovering unreported adverse events using your findings data

Richard Zink|October 25, 201111350
When designing case report forms (CRFs) for a clinical trial, it is important to minimize or eliminate redundancies in the collected information. Such redundancies can ... Read More

Summarizing the incidence of adverse events

Richard Zink|October 11, 201110931
The analysis of adverse events (AEs) suffers from the problem of dimensionality. It is impossible to predict what AEs will occur on study, and there ... Read More

JMP Clinical 3.1 generates adverse event narratives

Richard Zink|October 5, 201110390
In a clinical trial, when a subject has a serious adverse event (SAE) or other significant adverse event (AE), such as those leading to the ... Read More